<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  

Dadun > Depósito Académico > Clínica Universidad de Navarra > Alergología e Inmunología clínica > DA - CUN - Alergología e Inmunología clínica - Artículos de revista >

Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study I. clinical findings and in vitro diagnosis
Autor(es) : Weck, A.L. (A.L.) de
Sanz, M.L. (María Luisa)
Gamboa, P.M. (P. M.)
Aberer, W. (W.)
Blanca, M. (M.)
Correia, S. (S.)
Erdman, S. (S.)
Jermann, J.S. (J. S.)
Kanny, G. (G.)
Kowalski, M. (M.)
Mayorga, L. (L.)
Medrala, W. (W.)
Merk, A. (A.)
Sturm, G.J. (G.J.)
Sainte-Laudy, J. (J.)
Schneider, M.S. (M.S.)
Sczczeklik, A. (A.)
Weber, J.M. (J.M.)
Wedi, A. (A.)
Palabras clave : Hypersensitivity syndrome
Clinical findings
Basophil activation test
Fecha incorporación: 2009
Editorial : ESMON Publicidad
Versión del editor: http://www.jiaci.org/issues/vol19issue5/2.pdf
ISSN: 1018-9068
Cita: De Weck AL, Sanz ML, Gamboa PM, Aberer W, Blanca M, Correia S, et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. J Investig Allergol Clin Immunol 2009;19(5):355-369.
ackground: We present the results obtained from the largest series of in vitro diagnostic tests ever reported in patients with clinically validated hypersensitivity to acetylsalicylic acid (ASA)/nonsteroidal anti-infl ammatory drugs (NSAID) compared with various categories of controls tolerating ASA/NSAIDs. This multicenter study, which was performed within the framework of the European Network for Drug Allergy (ENDA) group, showed that the basophil activation test (BAT), particularly when used with the 3 NSAIDs aspirin (ASA), diclofenac (DIC), and naproxen (NAP), allows us to confi rm the diagnosis of NSAID hypersensitivity syndrome. The results of the cellular allergen stimulation test (CAST) frequently correlate with those of the BAT, although not always. An unexpected fi nding was that basophil activation by NSAIDs is not an all-or-nothing phenomenon restricted to clinically hypersensitive patients, but that it also occurs in a dose-related manner in some NSAID-tolerant control individuals. Therefore, NSAID hypersensitivity appears as a shift in the normal pharmacological response to NSAIDs. These fi ndings allow us to formulate a new rational hypothesis about the mechanism of NSAID hypersensitivity syndrome, a mechanism that most authors continue to describe as “unknown.” Methods: We enrolled 152 patients with a history of hypersensitivity to NSAIDs and 136 control participants in 11 different centers between spring 2003 and spring 2006. Flowcytometric BAT was performed. Results: The most noteworthy results of our study were that 57% of 140 patients presented very clear-cut positive BAT results to multiple NSAIDs, and 16% were entirely negative. In about 27% of cases, positive results were obtained with 1 or 2 concentrations of a single NSAID. There is clearly a correlation between the results of BAT and CAST. Conclusions: BAT seems particularly indicated in patients with a clinical history of NSAID intolerance, and in whom a provocation test is not advisable for ethical, clinical, or other reasons.
Enlace permanente: http://hdl.handle.net/10171/22527
Aparece en las colecciones: DA - CUN - Alergología e Inmunología clínica - Artículos de revista

Ficheros en este registro:
Fichero:  J Investig Allergol Clin Immuno. 2009.355.pdf
Tamaño:  167,22 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.